Study finds no clinically useful biomarkers for long COVID in routine lab tests

Whether tests in current use were adequate to identify post-acute sequelae of SARS-CoV-2 (PASC).

Johnson & Johnson seeks first drug approval for treatment of smoldering myeloma

This roundup of news from the ASH 2024 conference first appeared in STAT’s “ASH in 30” newsletter. To get future editions, sign up here. Welcome back,

December 9, 2024

How Minnesota figures into the presidential politics of insulin prices

In June 2019, Lija Greenseid handed Minnesota Gov. Tim Walz an empty vial of insulin that her 13-year-old daughter had painted gold.

October 1, 2024

Comprehensive review highlights impact of tobacco control measures

Tobacco use remains a significant global health challenge, despite extensive control measures at both national and international levels.

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.